HTG Molecular Diagnostics, Inc. (HTGMQ) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
3430 E. GLOBAL LOOP TUCSON, AZ 85706 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3826 - Laboratory Analytical Instruments (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 12,211 | 21,943 | 28,696 | 33,030 | 31,114 | 9,969 | |||
| Cash and cash equivalents | 12,211 | 9,600 | 22,398 | 7,620 | 8,433 | 9,969 | |||
| Short-term investments | 12,343 | 6,298 | 25,410 | 22,681 | |||||
| Restricted cash and investments | 3,270 | ||||||||
| Receivables | 1,422 | 2,092 | 1,589 | 3,164 | 5,013 | 6,356 | |||
| Inventory, net of allowances, customer advances and progress billings | 909 | 1,988 | 1,492 | 1,270 | 1,307 | 1,181 | |||
| Inventory | 909 | 1,988 | 1,492 | 1,270 | 1,307 | 1,181 | |||
| Deferred costs | 140 | 59 | 3 | ||||||
| Other undisclosed current assets | 1,110 | 1,163 | 1,094 | 493 | 509 | 440 | |||
| Total current assets: | 15,651 | 27,187 | 32,871 | 41,368 | 38,001 | 17,948 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,007 | 1,345 | 1,009 | 1,209 | ✕ | ✕ | |||
| Property, plant and equipment | 598 | 1,119 | 1,227 | 2,240 | 2,374 | 3,305 | |||
| Restricted cash and investments | 3,270 | ||||||||
| Deferred costs | 59 | 3 | |||||||
| Other noncurrent assets | 521 | 809 | 90 | 302 | |||||
| Other undisclosed noncurrent assets | 67 | ||||||||
| Total noncurrent assets: | 2,126 | 3,274 | 2,327 | 3,752 | 5,770 | 3,308 | |||
| TOTAL ASSETS: | 17,778 | 30,461 | 35,198 | 45,119 | 43,771 | 21,256 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,367 | 3,672 | 2,809 | 3,533 | 5,208 | 6,186 | |||
| Accounts payable | 1,157 | 1,649 | 1,349 | 1,663 | 1,850 | 2,439 | |||
| Accrued liabilities | 2,210 | 2,023 | 1,460 | 1,870 | 3,358 | 3,747 | |||
| Deferred revenue | 125 | 185 | 426 | ✕ | ✕ | ||||
| Debt | 3,812 | 5,168 | 3,022 | 3,747 | 5,794 | ||||
| Asset retirement obligation | 446 | 548 | 513 | 1,152 | 1,290 | 496 | |||
| Other liabilities | 170 | 17 | 23 | 41 | 186 | 200 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 666 | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 333 | ✕ | ||
| Other undisclosed current liabilities | 475 | 414 | 685 | ||||||
| Total current liabilities: | 8,271 | 9,944 | 7,236 | 8,899 | 7,017 | 13,342 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 6,159 | 8,985 | 7,508 | 9,679 | 2,961 | ||||
| Long-term debt, excluding current maturities | 5,179 | 8,568 | 6,872 | 9,679 | 2,961 | ||||
| Finance lease, liability | 31 | 48 | ✕ | ✕ | |||||
| Liabilities, other than long-term debt | 4,115 | 3,989 | 4,540 | 4,743 | 5,983 | 8,013 | |||
| Asset retirement obligations | 3,519 | 3,901 | 4,479 | 4,499 | 5,703 | 7,521 | |||
| Other liabilities | 50 | 88 | 60 | 244 | 280 | 492 | |||
| Operating lease, liability | 546 | 949 | 369 | 636 | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | (15) | (49) | (48) | ||||||
| Total noncurrent liabilities: | 4,100 | 10,100 | 13,477 | 12,251 | 15,662 | 10,974 | |||
| Other undisclosed liabilities | 15 | 17 | |||||||
| Total liabilities: | 12,386 | 20,061 | 20,713 | 21,150 | 22,679 | 24,316 | |||
| Equity | |||||||||
| Equity, attributable to parent | 5,392 | 10,400 | 14,485 | 23,970 | 21,092 | (3,060) | |||
| Preferred stock | 0 | 0 | |||||||
| Common stock | 2 | 8 | 5 | 58 | 29 | 14 | |||
| Additional paid in capital | 235,314 | 218,723 | 205,662 | 194,234 | 172,087 | 131,493 | |||
| Accumulated other comprehensive income (loss) | 3 | 2 | 5 | (5) | (3) | ||||
| Accumulated deficit | (229,928) | (208,333) | (191,188) | (170,318) | (151,020) | (134,566) | |||
| Total equity: | 5,392 | 10,400 | 14,485 | 23,970 | 21,092 | (3,060) | |||
| TOTAL LIABILITIES AND EQUITY: | 17,778 | 30,461 | 35,198 | 45,119 | 43,771 | 21,256 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 6,366 | 8,907 | 8,549 | 19,204 | 21,504 | 14,760 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 14,760 | |
| Cost of revenue | (4,572) | (4,095) | (3,992) | (8,911) | (5,090) | (4,972) | ||
| Cost of goods and services sold | (4,572) | (4,095) | (3,992) | (8,911) | (5,090) | (1,609) | ||
| Gross profit: | 1,794 | 4,812 | 4,557 | 10,293 | 16,413 | 9,788 | ||
| Operating expenses | (22,624) | (22,636) | (24,143) | (29,253) | (32,573) | (27,510) | ||
| Operating loss: | (20,830) | (17,824) | (19,586) | (18,960) | (16,159) | (17,723) | ||
| Nonoperating income (expense) | (754) | 701 | (1,270) | (334) | (291) | (1,234) | ||
| Interest and debt expense | (857) | (1,065) | (522) | (958) | (105) | (1,308) | ||
| Loss from continuing operations before equity method investments, income taxes: | (22,440) | (18,187) | (21,378) | (20,252) | (16,555) | (20,265) | ||
| Other undisclosed income from continuing operations before income taxes | 857 | 1,065 | 522 | 958 | 105 | 1,308 | ||
| Loss from continuing operations before income taxes: | (21,584) | (17,123) | (20,856) | (19,294) | (16,450) | (18,957) | ||
| Income tax expense | (11) | (22) | (14) | (3) | (4) | (3) | ||
| Loss from continuing operations: | (21,594) | (17,145) | (20,870) | (19,298) | (16,454) | (18,960) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (17,145) | (20,870) | (19,298) | (16,454) | (18,960) | ||
| Net loss available to common stockholders, diluted: | (21,594) | (17,145) | (20,870) | (19,298) | (16,454) | (18,960) | ||
Comprehensive Income ($ in thousands)
| 3/31/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (21,594) | (17,145) | (20,870) | (19,298) | (16,454) | (18,960) | ||
| Other comprehensive income (loss) | (3) | 10 | (2) | (3) | 1 | |||
| Other undisclosed comprehensive income | ||||||||
| Comprehensive loss: | (21,594) | (17,149) | (20,860) | (19,299) | (16,457) | (18,959) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 1 | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (21,594) | (17,149) | (20,860) | (19,299) | (16,457) | (18,959) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.